Filing Manager
Yun Yao
Reporting Manager
Yao Yun
Symbol
INDP
Shares outstanding
113,183,288 shares
Disclosed Ownership
41,991,000 shares
Ownership
37%
Form type
SCHEDULE 13D/A
Filing time
29 Apr 2026, 16:05:42 UTC
Date of event
28 Apr 2026
Previous filing
30 Mar 2026

Quoteable Key Fact

"Yun Yao disclosed 37% ownership in Indaptus Therapeutics, Inc. Common Stock, $0.01 par value (INDP) on 28 Apr 2026."

Quick Takeaways

  • Yun Yao filed SCHEDULE 13D/A for Indaptus Therapeutics, Inc. Common Stock, $0.01 par value (INDP).
  • Disclosed ownership: 37%.
  • Date of event: 28 Apr 2026.

What Changed

  • Previous schedule filing date: 30 Mar 2026.
  • Current filing was accepted on 29 Apr 2026, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Yao Yun 37% 41,991,000 41,991,000 0 /s/ Yun Yao Yun Yao 0002120637
SINO LION VENTURES Ltd 34% 38,895,000 0 38,895,000 /s/ Chenhao Xu Chenhao Xu / Authorized Signatory 0002120638
Xu Chenhao 34% 38,895,000 0 38,895,000 /s/ Chenhao Xu Chenhao Xu
Dai Junyi 9.9% 11,250,000 11,250,000 0 /s/ Junyi Dai Junyi Dai 0002022463
Yang Ting 9.9% 11,250,000 11,250,000 0 /s/ Ting Yang Ting Yang 0002120636
Deng Lina 4.9% 5,550,000 5,550,000 0 /s/ Lina Deng Lina Deng 0002120635
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .